Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Cerebral Blood Flow Regulation and Concussions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02754206
Recruitment Status : Recruiting
First Posted : April 28, 2016
Last Update Posted : October 4, 2018
Sponsor:
Information provided by (Responsible Party):
Sushmita Purkayastha, Southern Methodist University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to understand how biochemical markers in blood, balance disturbances, and cognitive performance are related to brain blood flow changes after a concussion.

Condition or disease
Brain Concussion Post-Concussion Syndrome

Detailed Description:
Comparisons will be made between control data and data following a concussion collected from athletes participating in contact-collision sports. For those suffering a concussion, comparisons will be made between day 3 (acute phase), day 21 (recovery phase), and 3 months post-concussion.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Association Between Brain Blood Flow Regulation, Cognition, and Balance in Sports-Related Concussion
Study Start Date : January 2016
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : January 2021
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Control
Subjects who are collegiate level athletes who do not have a concussion and are currently playing a contact-collision sport.
Concussed
Subjects who have recently suffered a sports-related concussion and are currently a collegiate athlete playing a contact-collision sport.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Cerebral blood flow regulation [ Time Frame: Change in Control, 3 days post concussion, 21 days post concussion, and 3 months post concussion ]
    Subject's cerebral blood flow regulation (cm/sec) at rest, during a cognitive test, and during a breathing test will be measured.


Secondary Outcome Measures :
  1. Blood Biomarkers [ Time Frame: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion ]
    Subjects will have their blood drawn so investigators can look at biomarkers in their blood. The biomarkers will be Tau, a-Spectrin N-Terminal Fragment, Neuron-specific enolase, Ubiquitin C-Terminal hydrolase L1, S100B, and Glial fibrillary acidic protein.

  2. Memory Function Test [ Time Frame: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion ]
    Subjects will be given paper tests to test their memory function.

  3. Balance Test [ Time Frame: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion ]
    Subjects balance will be measured using a force plate.

  4. Orthostatic Tolerance Test [ Time Frame: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion ]
    Subjects physiological measurements will be measured as the move from a seated position to a standing position.

  5. Cerebral Vasoreactivity [ Time Frame: Control, 3 days post concussion, 21 days post concussion, 3 months post concussion ]
    Subjects will breathe normal air, a 8% carbon dioxide gas mixture, and hyperventilate.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Collegiate Athletes who are currently playing a contact-collision sport.
Criteria

Inclusion Criteria:

  • Student athletes actively participating in collegiate sports. Subjects should be wiling to provide informed consent for participation in the study.

Exclusion Criteria:

  • Participants who are unable to play as a result of injury. Presence of irregular heart beat.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02754206


Contacts
Layout table for location contacts
Contact: Sushmita A Purkayastha, Ph.D 214-768-2193 spurkayastha@mail.smu.edu

Locations
Layout table for location information
United States, Texas
Southern Methodist University Recruiting
Dallas, Texas, United States, 75205
Contact: Sandy A Oswalt    214-768-4036    soswalt@mail.smu.edu   
Principal Investigator: Sushmita Purkayastha, Ph.D         
Sponsors and Collaborators
Southern Methodist University
Investigators
Layout table for investigator information
Principal Investigator: Sushmita Purkayastha, Ph.D Southern Methodist University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Sushmita Purkayastha, Assistant Professor, Southern Methodist University
ClinicalTrials.gov Identifier: NCT02754206    
Other Study ID Numbers: SouthernMethodist
First Posted: April 28, 2016    Key Record Dates
Last Update Posted: October 4, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Concussion
Post-Concussion Syndrome
Brain Injuries, Traumatic
Brain Injuries
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Head Injuries, Closed
Wounds and Injuries
Wounds, Nonpenetrating